Journal of Clinical Lipidology

Papers
(The H4-Index of Journal of Clinical Lipidology is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
A Single-Dose, Four-way-Crossover Comparative Bioavailability Study of Two Omega-3 Formulations under Fasting and Fed Conditions in Healthy Volunteers112
Treatment Gap in Prevention of Myocardial Infarction in Rural New York State101
News from NLA100
Genetic Testing for Hypertriglyceridemia in Academic Lipid Clinics - Implications for Precision Medicine93
The Effect of Estrogen and Testosterone on Cholesterol Crystallization58
Prevalence of Lipoprotein(a) Measurements in Patients with or at Risk of Cardiovascular Disease54
Evidence of Direct Hepatic Secretion of Low density Lipoprotein (LDL) in Mice52
†Role of DNA methylation on 15-Lipoxygenase-1 gene expression in Osteoarthritis51
Lower Activity of Cholesteryl Ester Transfer protein (CETP) and the Risk of Dementia: A Mendelian Randomization Analysis49
Multi-pathway cholesterol depletion on top of FOLFIRINOX in newly-diagnosed metastatic pancreatic adenocarcinoma47
Comparison of virtual vs face-to-face medical nutrition therapy in patients with hyperlipidemia44
From the Editors: New insights into lipid disorders in children and adolescents as well as cardiovascular benefits of pharmacotherapy for weight loss41
Mesenchymal Stromal Cell (MSC) Therapy Improve Nonalcoholic Fatty Liver Disease (NAFLD) in Long Term high Fat Diet (HFD) Induced Obesity (DIO) Mouse40
Lipoprotein(a) levels in children with homozygous familial hypercholesterolaemia: A cross-sectional study39
Intima-media thickness in treated and untreated patients with and without familial hypercholesterolemia: A systematic review and meta-analysis38
Relation of red blood cell distribution width to risk of major adverse cardiovascular events, death, and effect of alirocumab after acute coronary syndromes36
Impact of providing genetics-based future cardiovascular risk on LDL-C in patients with familial hypercholesterolemia34
Niacin (Niacin) and clinical utility, don't be misled by recent niacin (Niacin) metabolite report32
Hypertriglyceridemia during hospitalization independently associates with mortality in patients with COVID-1932
Achievement of low-density lipoprotein cholesterol thresholds in very high-risk atherosclerotic cardiovascular disease30
Assessment and management of statin-associated muscle symptoms (SAMS): A clinical perspective from the National Lipid Association29
Socioeconomic Disparities in Dyslipidemia and Associated Complications: From the Latest National Database28
Care of youth with lipid disorders: A brief provider survey26
Effective treatment of statin- and ezetimibe-resistant hyperlipidemia in a patient with active membranous nephrotic syndrome using a PCSK9 inhibitor25
Hypercoagulability or coronary artery disease? Polygenic risk score unveils the mystery24
0.038837909698486